pyridoxal has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cates, LA | 1 |
| Jones, GS | 1 |
| Good, DJ | 1 |
| Tsai, HY | 1 |
| Li, VS | 1 |
| Caron, N | 1 |
| Tu, SC | 1 |
| Kimball, AP | 1 |
| Struck, RF | 1 |
| Shealy, YF | 1 |
| Montgomery, JA | 1 |
2 other studies available for pyridoxal and Leukemia L 1210
| Article | Year |
|---|---|
Cyclophosphamide potentiation and aldehyde oxidase inhibition by phosphorylated aldehydes and acetals.
Topics: Acetals; Aldehyde Oxidoreductases; Aldehydes; Animals; Cyclophosphamide; Drug Synergism; Female; In | 1980 |
Vitamin B6 analogs. 4. 4-Desoxyisopyridoxal and the phosphonic acid analog of 4-desoxypyridoxine phosphate.
Topics: Animals; Cells, Cultured; Humans; In Vitro Techniques; Leukemia L1210; Organophosphonates; Organopho | 1971 |